EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 382 filers reported holding EXELIXIS INC in Q1 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | -85.7% | 62 | -81.0% | 0.00% | -100.0% |
Q3 2021 | $7,000 | +16.7% | 326 | 0.0% | 0.00% | +100.0% |
Q2 2021 | $6,000 | +500.0% | 326 | +425.8% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | -50.0% | 62 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | +100.0% | 62 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -83.3% | 62 | -84.1% | 0.00% | -100.0% |
Q4 2019 | $6,000 | -14.3% | 389 | +0.5% | 0.00% | 0.0% |
Q3 2019 | $7,000 | -12.5% | 387 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $8,000 | -11.1% | 387 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $9,000 | +28.6% | 387 | +2.7% | 0.00% | 0.0% |
Q4 2018 | $7,000 | +16.7% | 377 | 0.0% | 0.00% | +100.0% |
Q3 2018 | $6,000 | -25.0% | 377 | -2.6% | 0.00% | -50.0% |
Q2 2018 | $8,000 | -11.1% | 387 | -1.3% | 0.00% | 0.0% |
Q1 2018 | $9,000 | +12.5% | 392 | +304.1% | 0.00% | 0.0% |
Q4 2017 | $8,000 | – | 97 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
AJO, LP | 7,636,882 | $134,561,000 | 0.80% |